Biomarker Research

Table 1 Number of patients in the cohorts included in this study

From: A robust prognostic gene expression signature for early stage lung adenocarcinoma

		Included^a
Cohort	Available	Stage I	Stage II	Total
Lee et al. 2008 [4]	138	39	12	51
Zhu et al. 2010 [5]	133	20	12	32
Shedden et al. 2008 [6]	505	164	43	207
Rousseaux et al. 2013 [7]	307	81	3	84
Okayama et al. 2012 [8]	246	162	42	204
Botling et al. 2013 [9]	196	31	4	35
Der et al. 2014 [10]	181	92	35	127

^apassed inclusion criteria: adenocarcinoma, no chemotherapy

Back to article page

ISSN: 2050-7771

Contact us

General enquiries: journalsubmissions@springernature.com